DRMA CIK: 1853816

Dermata Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.86
FY22:
−9.67
FY23:
−8.04
FY24:
−12.5
FY25:
−7.77
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.86
FY22:
−9.67
FY23:
−8.04
FY24:
−12.5
FY25:
−7.77
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.90
FY22:
−9.61
FY23:
−7.79
FY24:
−12.3
FY25:
−7.56
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.90
FY22:
−9.61
FY23:
−7.79
FY24:
−12.3
FY25:
−7.56

All amounts in millions USD Data sources:SEC EDGARTwelve Data